Scholarlink

Background <p>Genus <i>Penicillium</i> represents one of the most prolific fungi in terms of biosynthesis of bioactive secondary metabolites. This review aims to survey the reported terpenoids isolated from different species of genus <i>Penicillium</i> and virtually screen their potential as xanthine oxidoreductase (XORs) inhibitors via in silico molecular modeling studies.</p> Results <p>More than 140 terpenoidal compounds were included in this study and evaluated for their in silico XOR inhibitory activity. The in silico study revealed that compounds 3-hydroxy-agathic acid (<b>27</b>), agathic acid (<b>28</b>), isopenicin A (<b>86</b>), decaturenol A (<b>108</b>), chermebilaene A (<b>137</b>), and 6-[(2E,6E)-10,11-dihydro-11-hydroxy-farnesyl]- 5,7-dihydroxy-4-methylphthalide (<b>142</b>) exhibit considerable inhibition of XOR potential.</p> Conclusion <p>The in silico XORs inhibition screening study revealed promising candidates from the terpenoidal pool reported from different <i>Penicillium sp</i>., and these candidates can be promoted for further in vitro<i>,</i> in vivo<i>,</i> and preclinical studies to validate the in silico results to support the anti-gout drug pipelines with potential natural products candidates.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Unveiling the anti-gout potential of terpenes isolated from Penicillium sp. supported by in silico studies

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年1月22日

查看全文
  • Abdelrhman M. Mohamed,
  • Shaza H. Aly,
  • Ahmed M. Elissawy,
  • Mohamed A. Elanany,
  • Rakesh K. Bachheti,
  • Abdel Nasser B. Singab

摘要

Background

Genus Penicillium represents one of the most prolific fungi in terms of biosynthesis of bioactive secondary metabolites. This review aims to survey the reported terpenoids isolated from different species of genus Penicillium and virtually screen their potential as xanthine oxidoreductase (XORs) inhibitors via in silico molecular modeling studies.

Results

More than 140 terpenoidal compounds were included in this study and evaluated for their in silico XOR inhibitory activity. The in silico study revealed that compounds 3-hydroxy-agathic acid (27), agathic acid (28), isopenicin A (86), decaturenol A (108), chermebilaene A (137), and 6-[(2E,6E)-10,11-dihydro-11-hydroxy-farnesyl]- 5,7-dihydroxy-4-methylphthalide (142) exhibit considerable inhibition of XOR potential.

Conclusion

The in silico XORs inhibition screening study revealed promising candidates from the terpenoidal pool reported from different Penicillium sp., and these candidates can be promoted for further in vitro, in vivo, and preclinical studies to validate the in silico results to support the anti-gout drug pipelines with potential natural products candidates.